240 related articles for article (PubMed ID: 15915352)
1. Effect of probenecid on the pharmacokinetics of carbamazepine in healthy subjects.
Kim KA; Oh SO; Park PW; Park JY
Eur J Clin Pharmacol; 2005 Jun; 61(4):275-80. PubMed ID: 15915352
[TBL] [Abstract][Full Text] [Related]
2. Effect of Piperine on the Metabolism and Pharmacokinetics of Carbamazepine in Healthy Volunteers.
Bedada SK; Appani R; Boga PK
Drug Res (Stuttg); 2017 Jan; 67(1):46-51. PubMed ID: 27776366
[TBL] [Abstract][Full Text] [Related]
3. A comparative pharmacokinetic study in healthy volunteers of the effect of carbamazepine and oxcarbazepine on cyp3a4.
Andreasen AH; Brøsen K; Damkier P
Epilepsia; 2007 Mar; 48(3):490-6. PubMed ID: 17346248
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of ciprofloxacin on the pharmacokinetics of carbamazepine in healthy adult male volunteers.
Shahzadi A; Javed I; Aslam B; Muhammad F; Asi MR; Ashraf MY; Zia-ur-Rahman
Pak J Pharm Sci; 2011 Jan; 24(1):63-8. PubMed ID: 21190921
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic interaction study between the new antiepileptic and CNS drug RWJ-333369 and carbamazepine in healthy adults.
Chien S; Bialer M; Solanki B; Verhaeghe T; Doose DR; Novak G; Yao C
Epilepsia; 2006 Nov; 47(11):1830-40. PubMed ID: 17116022
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and metabolic investigation of topiramate disposition in healthy subjects in the absence and in the presence of enzyme induction by carbamazepine.
Britzi M; Perucca E; Soback S; Levy RH; Fattore C; Crema F; Gatti G; Doose DR; Maryanoff BE; Bialer M
Epilepsia; 2005 Mar; 46(3):378-84. PubMed ID: 15730535
[TBL] [Abstract][Full Text] [Related]
7. The effects of probenecid on the disposition of risperidone and olanzapine in healthy volunteers.
Markowitz JS; Devane CL; Liston HL; Boulton DW; Risch SC
Clin Pharmacol Ther; 2002 Jan; 71(1):30-8. PubMed ID: 11823755
[TBL] [Abstract][Full Text] [Related]
8. Effect of resveratrol on the pharmacokinetics of carbamazepine in healthy human volunteers.
Bedada SK; Nearati P
Phytother Res; 2015 May; 29(5):701-6. PubMed ID: 25624269
[TBL] [Abstract][Full Text] [Related]
9. Modulation of CYP3A enzyme activity by diosmin and its consequence on carbamazepine pharmacokinetics in rats.
Bedada SK; Neerati P
Naunyn Schmiedebergs Arch Pharmacol; 2018 Feb; 391(2):115-121. PubMed ID: 29134244
[TBL] [Abstract][Full Text] [Related]
10. Effects of sinapic acid on hepatic cytochrome P450 3A2, 2C11, and intestinal P-glycoprotein on the pharmacokinetics of oral carbamazepine in rats: Potential food/herb-drug interaction.
Raish M; Ahmad A; Ansari MA; Alkharfy KM; Ahad A; Al-Jenoobi FI; Al-Mohizea AM; Khan A; Ali N
Epilepsy Res; 2019 Jul; 153():14-18. PubMed ID: 30927680
[TBL] [Abstract][Full Text] [Related]
11. Influence of diosmin on the metabolism and disposition of carbamazepine in healthy subjects.
Bedada SK; Boga PK
Xenobiotica; 2017 Oct; 47(10):879-884. PubMed ID: 27690733
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic interaction between efavirenz and carbamazepine after multiple-dose administration in healthy subjects.
Ji P; Damle B; Xie J; Unger SE; Grasela DM; Kaul S
J Clin Pharmacol; 2008 Aug; 48(8):948-56. PubMed ID: 18519918
[TBL] [Abstract][Full Text] [Related]
13. Serum carbamazepine concentrations in elderly patients: a case-matched pharmacokinetic evaluation based on therapeutic drug monitoring data.
Battino D; Croci D; Rossini A; Messina S; Mamoli D; Perucca E
Epilepsia; 2003 Jul; 44(7):923-9. PubMed ID: 12823575
[TBL] [Abstract][Full Text] [Related]
14. Lack of interaction between HEPP, a new antiepileptic agent, and carbamazepine in rabbits.
García AL; Medina RL; Pérez MR; Jung CH
Biopharm Drug Dispos; 2003 Jul; 24(5):205-9. PubMed ID: 12784320
[TBL] [Abstract][Full Text] [Related]
15. Telithromycin, but not montelukast, increases the plasma concentrations and effects of the cytochrome P450 3A4 and 2C8 substrate repaglinide.
Kajosaari LI; Niemi M; Backman JT; Neuvonen PJ
Clin Pharmacol Ther; 2006 Mar; 79(3):231-42. PubMed ID: 16513447
[TBL] [Abstract][Full Text] [Related]
16. A limited sampling method for the estimation of AUC and Cmax of carbamazepine and carbamazepine epoxide following a single and multiple dose of a sustained-release product.
Mahmood I; Chamberlin N
Br J Clin Pharmacol; 1998 Mar; 45(3):241-6. PubMed ID: 9517367
[TBL] [Abstract][Full Text] [Related]
17. Effects of Paeonia emodi on hepatic cytochrome P450 (CYP3A2 and CYP2C11) expression and pharmacokinetics of carbamazepine in rats.
Raish M; Ahmad A; Alkharfy KM; Jan BL; Mohsin K; Ahad A; Al-Jenoobi FI; Al-Mohizea AM
Biomed Pharmacother; 2017 Jun; 90():694-698. PubMed ID: 28419964
[TBL] [Abstract][Full Text] [Related]
18. Pioglitazone, an in vitro inhibitor of CYP2C8 and CYP3A4, does not increase the plasma concentrations of the CYP2C8 and CYP3A4 substrate repaglinide.
Kajosaari LI; Jaakkola T; Neuvonen PJ; Backman JT
Eur J Clin Pharmacol; 2006 Mar; 62(3):217-23. PubMed ID: 16447051
[TBL] [Abstract][Full Text] [Related]
19. Effect of valpromide on the pharmacokinetics of carbamazepine-10, 11-epoxide.
Pisani F; Fazio A; Oteri G; Spina E; Perucca E; Bertilsson L
Br J Clin Pharmacol; 1988 May; 25(5):611-3. PubMed ID: 3136790
[TBL] [Abstract][Full Text] [Related]
20. Effects of short-term lamotrigine treatment on pharmacokinetics of carbamazepine.
Malminiemi K; Keränen T; Kerttula T; Moilanen E; Ylitalo P
Int J Clin Pharmacol Ther; 2000 Nov; 38(11):540-5. PubMed ID: 11097146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
